| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |